Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Match Group (MTCH) To Report Q3 Earnings: Is A Beat In Store?

Published 10/31/2018, 09:42 PM
Updated 07/09/2023, 06:31 AM

Match Group, Inc. (NASDAQ:MTCH) is scheduled to release third-quarter 2018 results on Nov 6.

The company has surpassed the Zacks Consensus Estimate in the two of the trailing four quarters, recording an average positive surprise of 1.7%.

In the last reported quarter, Match Group delivered adjusted earnings of 41 cents per share, which surpassed the Zacks Consensus Estimate of 36 cents per share. Moreover, the figure increased from the year-ago earnings of 16 cents per share.

Revenues of $421.2 million surged 36% year over year and beat the Zacks Consensus Estimate of $413 million. Year-over-year growth was primarily driven by 27% increase in average subscriber base and 8% rise in Average Revenue per Subscriber (“ARPU”).

Notably, shares of Match Group have returned 87.6% in the past year, against the industry’s decline of 19.6%.

What to Expect?

Match Group anticipates fiscal third-quarter 2018 revenues to be in the range of $430 million to $440 million. The Zacks Consensus Estimate for revenues is pegged at $438.3 million (near the higher end of the guided range), representing an increase of approximately 27.6% from the year-ago quarter.

For third-quarter fiscal 2019, the Zacks Consensus Estimate for earnings is pegged at 36 cents per share, reflecting a rise of 89.5% from the year-ago quarter.

Favorable ESP

According to the Zacks model, a company with Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) along with a positive Earnings ESP has a good chance of beating estimates. The Sell-rated stocks (Zacks Rank #4 or 5) are best avoided.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Match Group has a Zacks Rank #2 and an Earnings ESP of +3.59%, which makes us optimistic regarding an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Let’s see how things are shaping up prior to this announcement.

Factors Influencing Q3 Results

Match Group is benefiting from increasing subscriber addition in the form of membership subscriptions. Total average subscribers in the second quarter came in at 7.7 million, surging 26.7% from the year-ago quarter. The Zacks Consensus Estimate is pegged at approximately 8 million for the to-be-reported quarter.

The company boasts of a robust product portfolio comprising Tinder, Match.com, Meetic, PlentyOfFish and OkCupid. Notably, portfolio expansion with the acquisition of 51% stake in Hinge, the NY-based “relationship” app also bodes well.

Management anticipates Tinder to be the key growth driver in the to-be-reported quarter. Notably, revenues from Tinder soared 136% year over year in the prior quarter. It remains as the key catalyst behind the company’s year-over-year growth. Tinder average subscribers increased 81% year over year and came in at 3.8 million.

Better-than-expected renewal rates for Gold are noteworthy. In the last reported quarter, Average Revenue per Subscriber (“ARPU”) in Tinder grew 33% year over year, primarily due to Gold adoption and a la carte revenues from subscribers.

In a bid to boost Gold adoption, the company recently rolled out “Top Picks” feature on Tinder. This feature is anticipated to bolster Tinder Gold subscribers, consequently aiding the company to generate incremental revenues, going forward. Tinder also introduced Tinder U service custom made for college going students.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moreover, expanding footprint in India, the biggest market in Asia with regard to Tinder, is likely to be a tailwind.

Other Stocks to Consider

Here are some other companies, which as per our model, also have the right combination of elements to post an earnings beat this quarter:

Himax Technologies, Inc. (NASDAQ:HIMX) has an Earnings ESP of +48.15% and a Zacks Rank #1. The company is slated to report third-quarter 2018 earnings on Nov 8. You can see the complete list of today’s Zacks #1 Rank stocks here.

CRISPR Therapeutics AG (NASDAQ:CRSP) has an Earnings ESP of +3.53% and a Zacks Rank #1. The company is expected to report third-quarter 2018 earnings on Nov 14.

ICU Medical, Inc. (NASDAQ:ICUI) has an Earnings ESP of +8.65% and a Zacks Rank #2. The company is slated to report third-quarter 2018 earnings on Nov 8.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Match Group, Inc. (MTCH): Free Stock Analysis Report

Himax Technologies, Inc. (HIMX): Free Stock Analysis Report

ICU Medical, Inc. (ICUI): Free Stock Analysis Report

CRISPR THERAPTC (CRSP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.